Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database.
Sign Up to like & getrecommendations! Published in 2021 at "Cadernos de saude publica"
DOI: 10.1590/0102-311x00077721
Abstract: The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal… read more here.
Keywords: renal urinary; remdesivir; pharmacovigilance database; use remdesivir ... See more keywords